We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03104842
Recruitment Status : Active, not recruiting
First Posted : April 7, 2017
Last Update Posted : January 25, 2023
Information provided by (Responsible Party):
Universitätsklinikum Hamburg-Eppendorf